Literature DB >> 6332166

Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group.

.   

Abstract

The Caerphilly and Speedwell studies are based on representative samples of over 3000 subjects in South Wales and over 2000 in Bristol. They include cross sectional studies of risk factors for prevalent ischaemic heart disease (IHD) and of determinants of those risk factors. Prospective studies based on over 2000 men aged 45-59 in each area have been set up. In addition to the examination of lipid and thrombosis factors of possible relevance to IHD, the studies also focus on possible dietary, hormonal, and psychological risk factors, both as possible "risk factors" for IHD and also as possible "determinants" of risk factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332166      PMCID: PMC1052363          DOI: 10.1136/jech.38.3.259

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  14 in total

1.  Incidence and presentation of myocardial infarction in an English community.

Authors:  L J Kinlen
Journal:  Br Heart J       Date:  1973-06

2.  Natural history of acute coronary heart attacks. A community study.

Authors:  A Armstrong; B Duncan; M F Oliver; D G Julian; K W Donald; M Fulton; W Lutz; S L Morrison
Journal:  Br Heart J       Date:  1972-01

3.  Coronary heart-attacks in East London.

Authors:  H T Pedoe; D Clayton; J N Morris; W Brigden; L McDonald
Journal:  Lancet       Date:  1975-11-01       Impact factor: 79.321

4.  Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.

Authors:  J R O'Brien; M D Etherington; S Jamieson; P Lawford; S V Lincoln; N J Alkjaersig
Journal:  Thromb Diath Haemorrh       Date:  1975-11-15

5.  Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure.

Authors:  A M Fehily; J E Milbank; J W Yarnell; T M Hayes; A J Kubiki; R D Eastham
Journal:  Am J Clin Nutr       Date:  1982-11       Impact factor: 7.045

6.  The effect of fatty fish on plasma lipid and lipoprotein concentrations.

Authors:  A M Fehily; M L Burr; K M Phillips; N M Deadman
Journal:  Am J Clin Nutr       Date:  1983-09       Impact factor: 7.045

7.  The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors.

Authors:  S G Haynes; S Levine; N Scotch; M Feinleib; W B Kannel
Journal:  Am J Epidemiol       Date:  1978-05       Impact factor: 4.897

8.  Prevalence of ischaemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years. The Speedwell study.

Authors:  D Bainton; C J Burns-Cox; P C Elwood; B Lewis; N E Miller; K Morgan; P M Sweetnam
Journal:  Br Heart J       Date:  1982-05

9.  Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.

Authors:  I A Baker; R Eastham; P C Elwood; M Etherington; J R O'Brien; P M Sweetnam
Journal:  Br Heart J       Date:  1982-05

10.  Smoking and other risk factors for coronary heart-disease in British civil servants.

Authors:  D D Reid; P J Hamilton; P McCartney; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

View more
  54 in total

1.  Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; L Ballam; J Morris; B K Butland; P M Sweetnam; P C Elwood
Journal:  BMJ       Date:  1999-04-17

2.  Cognitive function in the Caerphilly study: associations with age social class, education and mood.

Authors:  J E Gallacher; P C Elwood; C Hopkinson; P M Rabbitt; B T Stollery; P M Sweetnam; C Brayne; F A Huppert
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

3.  Childhood milk consumption is associated with better physical performance in old age.

Authors:  Kate Birnie; Yoav Ben-Shlomo; David Gunnell; Shah Ebrahim; Antony Bayer; John Gallacher; Jeff M P Holly; Richard M Martin
Journal:  Age Ageing       Date:  2012-04-26       Impact factor: 10.668

4.  Socio-economic disadvantage from childhood to adulthood and locomotor function in old age: a lifecourse analysis of the Boyd Orr and Caerphilly prospective studies.

Authors:  Kate Birnie; Richard M Martin; John Gallacher; Antony Bayer; David Gunnell; Shah Ebrahim; Yoav Ben-Shlomo
Journal:  J Epidemiol Community Health       Date:  2010-07-19       Impact factor: 3.710

Review 5.  Aspirin for everyone older than 50? Against.

Authors:  Colin Baigent
Journal:  BMJ       Date:  2005-06-18

Review 6.  Aspirin for everyone older than 50? For.

Authors:  Peter Elwood; Gareth Morgan; Ginevra Brown; Janet Pickering
Journal:  BMJ       Date:  2005-06-18

7.  Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort.

Authors:  Peter Elwood; Melissa Hack; Janet Pickering; Janie Hughes; John Gallacher
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

8.  Role of IGF-I, IGF-II and IGFBP-3 in lung function of males: the Caerphilly Prospective Study.

Authors:  Christopher J Green; Jeffrey M Holly; Charlotte E Bolton; Antony Bayer; Shah Ebrahim; John Gallacher; Yoav Ben-Shlomo
Journal:  Int J Mol Epidemiol Genet       Date:  2014-05-29

9.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

10.  Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS).

Authors:  John D Eicher; Luting Xue; Yoav Ben-Shlomo; Andrew D Beswick; Andrew D Johnson
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.